Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study.

Saved in:
Bibliographic Details
Title: Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study.
Authors: Nakai T; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan., Fukui S; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.; Center for Clinical Epidemiology, St Luke's International University, Tokyo, Japan.; Department of Emergency and General Medicine, Kyorin University School of Medicine, Tokyo, Japan.; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, USA., Sawada H; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.; Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA., Ikada Y; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan., Tamaki H; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan., Kishimoto M; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.; Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan., Okada M; Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
Source: Lupus [Lupus] 2023 Nov; Vol. 32 (13), pp. 1518-1527. Date of Electronic Publication: 2023 Oct 19.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first